Renova is exploring new therapeutic opportunities that have the potential to expand the use of Renova's gene therapy platform to include several pathologies associated with diabetes and heart failure.

The present study was aimed to assess the safety and efficacy of a new dedicated shockwave device, 'Renova', which was designed to achieve substantially superior organ coverage, compared with the ...